BMRN vs UNG · P/E 40, rev $1.76B vs rev $7.6M
Biomarin Pharmaceutical Inc (BMRN) versus United States Natural Gas Fund LP (UNG) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
United States Natural Gas Fund LP (UNG) common stock listed on US.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported UNG revenue for 2025-12-31 was $7.6M. Net income was $34.2M. Revenue was up 113.9% from 2025-09-30 to 2025-12-31. UNG currently screens at market cap $0.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. UNG currently screens at market cap $0.
Not investment advice. Open the BMRN and UNG stock pages for the full models.
Not investment advice.